| Literature DB >> 33217317 |
Hui-Lung Sun1, Allen C Zhu2, Yawei Gao3, Hideki Terajima1, Qili Fei1, Shun Liu1, Linda Zhang1, Zijie Zhang1, Bryan T Harada1, Yu-Ying He4, Marc B Bissonnette5, Mien-Chie Hung6, Chuan He7.
Abstract
N6-methyladenosine (m6A) is the most abundant mRNA modification and is installed by the METTL3-METTL14-WTAP methyltransferase complex. Although the importance of m6A methylation in mRNA metabolism has been well documented recently, regulation of the m6A machinery remains obscure. Through a genome-wide CRISPR screen, we identify the ERK pathway and USP5 as positive regulators of the m6A deposition. We find that ERK phosphorylates METTL3 at S43/S50/S525 and WTAP at S306/S341, followed by deubiquitination by USP5, resulting in stabilization of the m6A methyltransferase complex. Lack of METTL3/WTAP phosphorylation reduces decay of m6A-labeled pluripotent factor transcripts and traps mouse embryonic stem cells in the pluripotent state. The same phosphorylation can also be found in ERK-activated human cancer cells and contribute to tumorigenesis. Our study reveals an unrecognized function of ERK in regulating m6A methylation. Published by Elsevier Inc.Entities:
Keywords: ERK; METTL3 phosphorylation; USP5; m(6)A methylation; stem cell differentiation
Mesh:
Substances:
Year: 2020 PMID: 33217317 PMCID: PMC7720844 DOI: 10.1016/j.molcel.2020.10.026
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970